Definium Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
Definium Therapeutics, Inc. (DFTX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price of $10.25 per share as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice · last filed 2026-08-06
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price 26.05 CAD/shares.
- 2023-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price 25.82 CAD/shares.
- 2023-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price 25.43 CAD/shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price 25.76 CAD/shares.
CAD/shares
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2023-12-31 | 26.05 CAD/shares 10-K · filed 2024-02-28 |
| 2023-09-30 | 25.82 CAD/shares 10-Q · filed 2023-11-02 |
| 2023-06-30 | 25.43 CAD/shares 10-Q · filed 2023-08-03 |
| 2022-12-31 | 25.76 CAD/shares 10-K · filed 2023-03-09 |
| 2022-09-30 | 24.79 CAD/shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 1.57 CAD/shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 1.51 CAD/shares 10-Q · filed 2022-05-16 |
| 2021-12-31 | 1.07 CAD/shares 10-K · filed 2022-03-28 |
USD/shares
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $10.25 10-Q · filed 2026-08-06 |
| 2026-03-31 | $14.76 10-Q · filed 2026-05-07 |
| 2025-12-31 | $16.62 10-K · filed 2026-02-26 |
| 2025-09-30 | $18.06 10-Q · filed 2025-11-06 |
| 2025-06-30 | $19.42 10-Q · filed 2025-07-31 |
| 2025-03-31 | $18.52 10-Q · filed 2025-05-08 |
| 2024-12-31 | $18.70 10-K · filed 2025-03-06 |
| 2024-09-30 | $19.30 10-Q · filed 2024-11-07 |
| 2024-06-30 | $19.73 10-Q · filed 2024-08-13 |
| 2023-03-31 | $26.43 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |